Breakthrough Designation in ALL, HIFU FDA Approval, Breast Cancer Screening Update, and More
Gina Columbus reports on a breakthrough therapy designation for inotuzumab ozogamicin for acute lymphoblastic leukemia, FDA clearance for high-intensity focused ultrasound for prostate cancer, and updates to the American Cancer Society’s breast cancer screening guidelines for those at average risk.
Focused ultrasound therapy uses ultrasound waves to guide the application of focused, high-intensity ultrasound waves through the skin down to the target tissue.
Breast Conservancy Therapy
Marketed in India By :
Incredible Medtech LLP
#D-102 Victoria Garden Tower
M2K Opp. Metro Station Azadpur
Ph.011-46241164 / 23858972 / 9810284657 /9958047250
E.mail : email@example.com